Skip to content
ClinCalc Pro
Menu
Benzodiazepine Hypnotic — Long-acting

Nitrazepam

Brand names: Mogadon

Nitrazepam is a long-acting benzodiazepine used for the short-term treatment of insomnia.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It potentiates the inhibitory neurotransmitter GABA at the GABA-A receptor, enhancing chloride channel opening to produce sedative, hypnotic and anxiolytic effects.

Prescribing in practice

  • Benzodiazepines should be prescribed for the shortest possible time because of the risk of tolerance, dependence and withdrawal, and nitrazepam's long half-life predisposes to next-day sedation and accumulation, especially in older people.
  • There is additive central nervous system and respiratory depression with alcohol and other sedatives, including opioids.
  • Avoid abrupt discontinuation after regular use, as this can precipitate a withdrawal syndrome; withdraw gradually.

Monitoring

Review the continued need for treatment regularly and monitor for daytime drowsiness, falls and signs of dependence.

Counselling the patient

  • This medicine can cause drowsiness the next day; take care when driving or operating machinery.
  • Avoid alcohol while taking nitrazepam.
  • Do not stop suddenly after taking it regularly; your prescriber will help you reduce it gradually.

Evidence & guidelines

Guidance from NICE and the MHRA emphasises short-term, lowest-effective use of hypnotic benzodiazepines such as nitrazepam because of dependence and next-day impairment.

Reference: NICE NG215 (Insomnia); Beers Criteria; STOPP/START Criteria; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.